This inventor holds 1 USPTO granted patent. Top assignee: Gist-Brocades N.v.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Eduardo Montenegro Prieto: Innovator in Antibiotic Production
Introduction
Eduardo Montenegro Prieto is a notable inventor based in Leon, Spain. He has made significant contributions to the field of antibiotic production, particularly in the enhancement of .beta.-lactam antibiotics. His innovative work has implications for the pharmaceutical industry and the development of essential medications.
Latest Patents
Eduardo holds a patent for a method that influences .beta.-lactam antibiotic production. This patent, titled "Method for influencing .beta.-lactam antibiotic production," provides novel methods and compositions for the enhanced production of .beta.-lactam antibiotics, exemplified by penicillin. The patent also includes the isolation and sequencing of the P. chrysogenum and A. chrysogenum .delta.-(L-.alpha.-aminoadipyl)-L-cysteinyl-D-valine synthetase genes. Furthermore, it outlines methods for producing .delta.-(L-.alpha.-aminoadipyl)-L-cysteinyl-D-valine synthetase using recombined DNA techniques. Eduardo has 1 patent to his name.
Career Highlights
Eduardo is associated with Gist-Brocades N.V., a company known for its advancements in biotechnology and fermentation processes. His work at the company has allowed him to focus on innovative solutions in antibiotic production, contributing to the development of effective treatments.
Collaborations
Throughout his career, Eduardo has collaborated with esteemed colleagues, including Annemarie Eveline Veenstra and Juan F Martin. These collaborations have fostered a productive environment for research and innovation in the field of antibiotics.
Conclusion
Eduardo Montenegro Prieto's contributions to antibiotic production highlight the importance of innovation in healthcare. His work continues to influence the development of essential medications, showcasing the impact of dedicated inventors in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile